Correlation Between X4 Pharmaceuticals and Kronos Bio

Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Kronos Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Kronos Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between X4 Pharmaceuticals and Kronos Bio, you can compare the effects of market volatilities on X4 Pharmaceuticals and Kronos Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Kronos Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Kronos Bio.

Diversification Opportunities for X4 Pharmaceuticals and Kronos Bio

0.35

Correlation Coefficient

X4 Pharmaceuticals  Kronos Bio

Weak diversification

The 3 months correlation between XFOR and Kronos is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Kronos Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kronos Bio and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Kronos Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kronos Bio has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Kronos Bio go up and down completely randomly.

Pair Corralation between X4 Pharmaceuticals and Kronos Bio

Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 3.33 times more return on investment than Kronos Bio. However, X4 Pharmaceuticals is 3.33 times more volatile than Kronos Bio. It trades about 0.05 of its potential returns per unit of risk. Kronos Bio is currently generating about 0.02 per unit of risk. If you would invest  66.00  in X4 Pharmaceuticals on September 26, 2024 and sell it today you would lose (8.00) from holding X4 Pharmaceuticals or give up 12.12% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

X4 Pharmaceuticals  vs.  Kronos Bio

X4 Pharmaceuticals

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in X4 Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, X4 Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Kronos Bio

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Kronos Bio are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Kronos Bio is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with X4 Pharmaceuticals and Kronos Bio

The main advantage of trading using opposite X4 Pharmaceuticals and Kronos Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Kronos Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kronos Bio will offset losses from the drop in Kronos Bio's long position.

The idea behind X4 Pharmaceuticals and Kronos Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.